TissueGene | Cell Tribune: Cell and Gene Therapy News and Research

Cell Therapy

BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor®...

Cell Tribune - December 21, 2016 0

BOTHELL, Wash., - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation...

Tag: TissueGene

BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor®...

EVEN MORE NEWS

U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...

New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing...

Sonoma Biotherapeutics launches with $40 million in Series A funding to...

POPULAR CATEGORY